ZVS106e

· Zhongshan Ophthalmic Center, Sun Yat-sen University

Drug timelines are a Plus or Pro feature.

1 regulatory and trial event tracked for ZVS106e, covering 2026-04-16 to 2026-04-16. Get the full timeline:

Most recent: Clinical Trial Update: The Safety and Efficacy of ZVS106e in the Treatment of IRDs Caused by Biallelic Mutations in ABCA4 [EARLY_Phase 1]

See pricing